Intrauterine Insemination Devices Industry - Regional Synopsis
North American Market Forecast
North America industry is likely to account for largest revenue share by 2037. The growth of the market can be attributed majorly to the increasing incidence of infertility across the region. The growth of the market can be accounted for by the surge in the number of infertility treatment clinics being set up in developing countries to cater to the growing demand for artificial insemination in the region. For instance, in every 4 women in the USA, 1 of them suffers from infertility which sums up to 25% of the total population of heterosexual women. While this rate is increasing exponentially with a total rate of around 11% annually. Furthermore, the spike in drug abuse in the region by adults and increasing smoking habits are further anticipated to expand the market size over the forecast period. Hence, all these factors are estimated to boost the growth of the market during the forecast period.
APAC Market Statistics
Furthermore, the global intrauterine insemination devices market is also anticipated to hold the second-largest share in the Asia Pacific region over the forecast period. The growing awareness of assisted reproductive techniques (ARTs) to conceive backed by the growing prevalence of infertility is expected to hike the market growth during the forecast period. Almost 28 million couples in India preferred alternative treatment options for conception. Furthermore, over 1600 IVF clinics and hospitals perform an average of 225,000 ART cycles in a year in India. Additionally, the growing prevalence of drug abuse in the region coupled with upsurged smoking habits is also expected to fuel the market growth in the projected timeframe.
